An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy
N/A
To test the hypothesis that AGT103-T cells therapy will allow HIV positive ...
Impact of a Short-Term Analytical Treatment Interruption and Re-Initiation of Antiretroviral Therapy on Immunologic and Virologic Parameters in HIV-Infected Individuals
N/A
Background:
The immune system helps the body fight off disease. Most peopl...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-07-17
Trial ID
NCT03225118
The SUSTAIN 2 Study - SUStained HIV Treatment for Adherence After Interruption in Care
NA
The goal of this clinical trial is to learn if the DSD model (SUSTAIN-DSD) ...